Data Science Funding Announcements & Notices
Data science and informatics funding announcements and notices are available from NCI and NIH programs. Browse below for opportunities, requests for information, notices, and initiatives.
| Title Sort descending | FOA | Organization | Release Date | Expire Date | Purpose |
|---|---|---|---|---|---|
| Alcohol Health Services Research (R01 Clinical Trial Optional) | PAR-23-251 | NIAAA | The National Institute on Alcohol Abuse and Alcoholism solicits applications for an R01 Clinical Trial Optional mechanism focusing on alcohol health services. This NOFO will broadly focus on closing… More | ||
| Alcohol Health Services Research (R34 Clinical Trial Optional) | PAR-23-252 | NIAAA | The National Institute on Alcohol Abuse and Alcoholism solicits applications for an R34 Clinical Trial Optional mechanism focusing on alcohol health services. This NOFO will broadly focus on closing… More | ||
| Alcohol Research-Related Resource Award (R24 Clinical Trial Not Allowed) | PAR-24-071 | NIAAA | The purpose of the Resource-Related Research Projects (R24) grant is to support investigator-initiated resources designed to provide materials and services to support and advance biomedical research… More | ||
| Alcohol Treatment, Pharmacotherapy, and Recovery Research (R01 Clinical Trial Required) | PAR-23-250 | NIAAA | The National Institute on Alcohol Abuse and Alcoholism solicits applications for an R01 Clinical Trial Required mechanism focusing on alcohol treatment and recovery research. This NOFO will focus… More | ||
| Alcohol Treatment, Pharmacotherapy, and Recovery Research (R34 Clinical Trial required) | PAR-23-249 | NIAAA | The National Institute on Alcohol Abuse and Alcoholism solicits applications for an R34 Clinical Trial Optional mechanism focusing on alcohol health services. This NOFO will broadly focus on closing… More | ||
| Alzheimer's Disease Research Centers (P30 Clinical Trial Not Allowed) | RFA-AG-24-001 | NIA | This Funding Opportunity Announcement (FOA) invites applications from institutions proposing to develop, or renew, an Alzheimer's Disease Research Center (ADRC). The National Institute on Aging… More | ||
| Alzheimer's Drug-Development Program (U01 Clinical Trial Optional) | PAR-22-047 | NIA | The goal of this Funding Opportunity Announcement (FOA) is to provide funding support for the pre-clinical and early stage clinical (Phase I) development of novel small-molecule and biologic drug… More | ||
| Analytical and Clinical Validation of Biomarkers for Alzheimers Disease (AD) and AD-Related Dementias (ADRD) (U01 Clinical Trial Optional) | PAR-23-258 | NIA | The goal of this Notice of Funding Opportunity (NOFO) is to accelerate the establishment ofeffective and reliable biomarkers of Alzheimers disease (AD) and AD-related dementias (ADRD) for usein… More | ||
| Analytical Validation of a Candidate Biomarker for Neurological or Neuromuscular Disorders (U44 Clinical Trial Optional) | PAR-24-098 | NINDS | (Reissue PAR-21-057) The purpose of this Program Announcement (PAR) is to enable analytical validation of strong candidate biomarkers for neurological diseases and conditions. Specifically, the goal… More | ||
| Analytical Validation of a Candidate Biomarker for Neurological or Neuromuscular Disorders(U01 Clinical Trial Optional) | PAR-24-095 | NINDS | (Reissue PAR-21-056) The purpose of this Program Announcement (PAR) is to enable analytical validation of strong candidate biomarkers for neurological diseases and conditions. Specifically, the goal… More |